Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate
about
Tumor blood flow differs between mouse strains: consequences for vasoresponse to photodynamic therapyEarly assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response.Study of tissue oxygen supply rate in a macroscopic photodynamic therapy singlet oxygen model.Near-infrared diffuse correlation spectroscopy in cancer diagnosis and therapy monitoring.Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapyPhoto-induced antitumor effect of 3,6-bis(1-methyl-4-vinylpyridinium) carbazole diiodide.Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinomaEvaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.Evaluation of verteporfin pharmakokinetics--redefining the need of photosensitizers in ophthalmology.Folic acid conjugated ferritins as photosensitizer carriers for photodynamic therapy.Tumor vascular microenvironment determines responsiveness to photodynamic therapy.Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma.Blood flow dynamics during local photoreaction in a head and neck tumor model
P2860
Q28729877-91DE072E-5D6F-453C-9D9F-B28DC993483CQ30358075-E3B46EB4-C065-4050-B0D6-1C4BED690C07Q35766780-E757C45F-28CF-486B-97D0-3435540AC004Q35777005-DB2D2732-7281-4458-B664-D0AB2D4B31E6Q36051401-495370DD-6D91-4B98-ADA0-B0E977960DC2Q36320158-C30C05FF-E8C6-43F5-B946-F31E5205E750Q36665110-C74E0F71-9F1D-487E-A676-18FC7271DBDAQ36687568-8564169A-0A9E-472E-958E-CC0C6FF12A54Q37507149-C01761C4-69C4-4C6E-83DF-AA5F5C6AAD3DQ38023892-B64449B7-F0D8-4B19-BBF3-1DB8222F0845Q38872171-8122BBBD-7778-4EAE-B4CF-FF2D0234EF16Q39388400-FEF950AE-D88A-49CF-BC1B-E7A83B5ED42CQ49816412-454C51A0-9717-4FDF-9380-155424400BDFQ51556954-093354D9-6277-44EB-B313-D16800D8BA34Q58561458-EE60565C-65FE-4E40-9174-1A9FCB54D94A
P2860
Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increasing damage to tumor blo ...... hrough use of low fluence rate
@ast
Increasing damage to tumor blo ...... hrough use of low fluence rate
@en
Increasing damage to tumor blo ...... hrough use of low fluence rate
@nl
type
label
Increasing damage to tumor blo ...... hrough use of low fluence rate
@ast
Increasing damage to tumor blo ...... hrough use of low fluence rate
@en
Increasing damage to tumor blo ...... hrough use of low fluence rate
@nl
prefLabel
Increasing damage to tumor blo ...... hrough use of low fluence rate
@ast
Increasing damage to tumor blo ...... hrough use of low fluence rate
@en
Increasing damage to tumor blo ...... hrough use of low fluence rate
@nl
P2093
P2860
P356
P1433
P1476
Increasing damage to tumor blo ...... hrough use of low fluence rate
@en
P2093
E Paul Wileyto
Guoqiang Yu
Hsing-Wen Wang
Ralph M Bunte
Theresa M Busch
P2860
P304
P356
10.1667/RR2075.1
P577
2010-09-01T00:00:00Z